Literature DB >> 21336544

St. John's wort may relieve negative effects of stress on spatial working memory by changing synaptic plasticity.

Emil Trofimiuk1, Adam Holownia, Jan J Braszko.   

Abstract

Beneficial effects of St. John's wort (Hypericum perforatum) in the treatment of stress-evoked memory impairment were recently described. In this study, we tested a hypothesis that St. John's wort alleviates stress- and corticosterone-related memory impairments by restoring levels of synaptic plasticity proteins: neuromoduline (GAP-43) and synaptophysin (SYP) in hippocampus and prefrontal cortex. Stressed and corticosterone-treated rats displayed a decline in the acquisition of spatial working memory (p < 0.001) in the Barnes maze (BM). Chronic administration of H. perforatum (350 mg kg(-1) for 21 days), potently and significantly improved processing of spatial information in the stressed and corticosterone-injected rats (p < 0.001). Also, St Johns' wort statistically significantly (p < 0.05) increased levels of GAP-43 and SYP, respectively in the hippocampi and prefrontal cortex as measured by western immunoblotting. We found that H. perforatum prevented the deleterious effects of both chronic restraint stress and prolonged corticosterone administration on working memory measured in the BM test. The herb significantly (p < 0.01) improved hippocampus-dependent spatial working memory in comparison with control and alleviated some other negative effects of stress on cognitive functions. These findings increase our understanding of the reaction of the hippocampus and prefrontal cortex to stressful assaults and provide new insight into the possible actions of H. perforatum in the treatment of patients with impaired adaptation to environmental stressors and simultaneously suffering from cognitive impairment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21336544     DOI: 10.1007/s00210-011-0604-3

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  44 in total

1.  Increase of the RNA-binding protein HuD and posttranscriptional up-regulation of the GAP-43 gene during spatial memory.

Authors:  Alessia Pascale; Pavel A Gusev; Marialaura Amadio; Tania Dottorini; Stefano Govoni; Daniel L Alkon; Alessandro Quattrone
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

2.  Enhanced synaptophysin immunoreactivity in rat hippocampal culture by 5-HT 1A agonist, S100b, and corticosteroid receptor agonists.

Authors:  M Nishi; P M Whitaker-Azmitia; E C Azmitia
Journal:  Synapse       Date:  1996-05       Impact factor: 2.562

3.  Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits.

Authors:  C Mazer; J Muneyyirci; K Taheny; N Raio; A Borella; P Whitaker-Azmitia
Journal:  Brain Res       Date:  1997-06-20       Impact factor: 3.252

4.  Hippocampal neuron and synaptophysin-positive bouton number in aging C57BL/6 mice.

Authors:  M E Calhoun; D Kurth; A L Phinney; J M Long; J Hengemihle; P R Mouton; D K Ingram; M Jucker
Journal:  Neurobiol Aging       Date:  1998 Nov-Dec       Impact factor: 4.673

5.  Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins.

Authors:  S L Eastwood; P J Harrison
Journal:  Brain Res Bull       Date:  2001-07-15       Impact factor: 4.077

Review 6.  GAP-43: an intrinsic determinant of neuronal development and plasticity.

Authors:  L I Benowitz; A Routtenberg
Journal:  Trends Neurosci       Date:  1997-02       Impact factor: 13.837

7.  Psychotropic effects of angiotensin II and III in rats: locomotor and exploratory vs cognitive behaviour.

Authors:  J J Braszko; K Wiśniewski; G Kupryszewski; B Witczuk
Journal:  Behav Brain Res       Date:  1987-09       Impact factor: 3.332

Review 8.  A focus on the synapse for neuroprotection in Alzheimer disease and other dementias.

Authors:  Paul Coleman; Howard Federoff; Roger Kurlan
Journal:  Neurology       Date:  2004-10-12       Impact factor: 9.910

9.  Alleviation by Hypericum perforatum of the stress-induced impairment of spatial working memory in rats.

Authors:  Emil Trofimiuk; Jan J Braszko
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

10.  Developmental changes in B-50 (GAP-43) in primary cultures of cerebral cortex: B-50 immunolocalization, axonal elongation rate and growth cone morphology.

Authors:  G J Ramakers; A B Oestreicher; P S Wolters; F W van Leeuwen; P N De Graan; W H Gispen
Journal:  Int J Dev Neurosci       Date:  1991       Impact factor: 2.457

View more
  6 in total

Review 1.  The mechanisms of action of St. John's wort: an update.

Authors:  Mathias Schmidt; Veronika Butterweck
Journal:  Wien Med Wochenschr       Date:  2015-07-17

2.  Reduced Alzheimer's disease pathology by St. John's Wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice.

Authors:  Jacqueline Hofrichter; Markus Krohn; Toni Schumacher; Cathleen Lange; Björn Feistel; Bernd Walbroel; Hans-Jochen Heinze; Sara Crockett; Timothy F Sharbel; Jens Pahnke
Journal:  Curr Alzheimer Res       Date:  2013-12       Impact factor: 3.498

3.  Candesartan prevents impairment of recall caused by repeated stress in rats.

Authors:  Jan Józef Braszko; Dominik Wincewicz; Piotr Jakubów
Journal:  Psychopharmacology (Berl)       Date:  2012-08-14       Impact factor: 4.530

Review 4.  Hypericum perforatum as a cognitive enhancer in rodents: A meta-analysis.

Authors:  Daniel Ben-Eliezer; Eldad Yechiam
Journal:  Sci Rep       Date:  2016-10-20       Impact factor: 4.379

5.  Neurotrophic, Cytoprotective, and Anti-inflammatory Effects of St. John's Wort Extract on Differentiated Mouse Hippocampal HT-22 Neurons.

Authors:  Gabriel A Bonaterra; Anna Schwendler; Julian Hüther; Hans Schwarzbach; Anja Schwarz; Christiane Kolb; Heba Abdel-Aziz; Ralf Kinscherf
Journal:  Front Pharmacol       Date:  2018-01-18       Impact factor: 5.810

Review 6.  Clinical relevance of St. John's wort drug interactions revisited.

Authors:  Simon Nicolussi; Jürgen Drewe; Veronika Butterweck; Henriette E Meyer Zu Schwabedissen
Journal:  Br J Pharmacol       Date:  2020-01-17       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.